Koji Izutsu

机构：National Cancer Centre Japan, National Cancer Center, National Cancer Center Hospital East, Tokyo National Hospital, Toranomon Hospital, National Cancer Research Institute · ORCID：0000-0001-9129-8057

发表论文 622 篇 · 总被引 12974 次 · h-index 52

代表论文

Lisocabtagene maraleucel in patients with relapsed or refractory marginal zone lymphoma (TRANSCEND FL): primary analysis results from the global, multicohort, single-arm, phase 2 study (2026 · The Lancet · 被引 8)
Lenalidomide Plus Rituximab for Relapsed/Refractory Indolent Non-Hodgkin Lymphoma: 5-Year Follow-Up and Subgroup Analyses From the Phase III AUGMENT Trial (2026 · Journal of Clinical Oncology · 被引 2)
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial (2026 · The Lancet Haematology · 被引 1)
Circulating Tumor DNA Assessment of Disease Response in Large B-Cell Lymphoma: Lisocabtagene Maraleucel Versus Autologous Stem Cell Transplantation Standard Therapy (2026 · Journal of Clinical Oncology · 被引 1)
Duvelisib Induces Deep Responses in Peripheral T-Cell Lymphoma: Final Results of the Phase II PRIMO Trial of Duvelisib in Relapsed/Refractory Peripheral T-Cell Lymphoma (2026 · Journal of Clinical Oncology · 被引 1)
Lenalidomide plus rituximab for previously untreated advanced follicular lymphoma: the 10-year RELEVANCE trial analysis (2026 · Blood · 被引 1)